Exact Mass: 271.99194439999997
Exact Mass Matches: 271.99194439999997
Found 52 metabolites which its exact mass value is equals to given mass value 271.99194439999997,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(Z)-4-(2-Hydroxy-5-sulfonatophenyl)-2-oxo-3-butenoate
Zoledronate
Zoledronate (zoledronic acid, marketed by Novartis under the trade names Zometa and Reclast) is a bisphosphonate. Zometa is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases. An annual dose of Zoledronate may also prevent recurring fractures in patients with a previous hip fracture. Zoledronate is a single 5 mg infusion for the treatment of Pagets disease of bone. In 2007, the FDA also approved Reclast for the treatment of postmenopausal osteoporosis. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
Hexose monophosphate
Zoledronic acid
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
Zoledronate
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
4,5-dichloro-2-(2-fluorobenzyl)pyridazine-3(2h)-one
C11H7Cl2FN2O (271.99194439999997)
4-CHLORO-2-CHLOROMETHYL-5,6,7,8-TETRAHYDRO-BENZO[4,5]THIENO[2,3-D]PYRIMIDINE
C11H10Cl2N2S (271.99417200000005)
Z-2-(2,3-Dichlorophenyl)methylene-3-oxobutanoic acid methyleater
C12H10Cl2O3 (272.00069700000006)
(3-Bromo-5-(ethoxycarbonyl)phenyl)boronic acid
C9H10BBrO4 (271.98554700000005)
1-(CHLOROMETHYL)-4-(METHYLSULFONYL)-2-(TRIFLUOROMETHYL)BENZENE
Methyl 2-(2,3-dichlorobenzylidine)acetoacetate
C12H10Cl2O3 (272.00069700000006)
7-BROMO-6-FLUORO-3,3-DIMETHYL-3,4-DIHYDROQUINOXALIN-2(1H)-ONE
C10H10BrFN2O (271.99604819999996)
6,8-DICHLORO-2H-CHROMENE-3-CARBOXYLIC ACID ETHYL ESTER
C12H10Cl2O3 (272.00069700000006)
5-BROMO-2-(CYCLOHEXYLTHIO)PYRIMIDINE
C10H13BrN2S (271.99827580000004)
2-[(2,4-Dichlorophenyl)methylthio]-1-methylimidazole
C11H10Cl2N2S (271.99417200000005)
(7-Hydroxy-1-oxoisochromen-3-yl)methyl hydrogen sulate
(Z)-4-(2-hydroxy-5-sulfo-phenyl)-2-oxo-but-3-enoic Acid
2-Methylcitric acid (trisodium)
2-Methylcitric acid trisodium (Methylcitric acid trisodium) is an endogenous metabolite in the 2-methylcitric acid cycle. 2-Methylcitric acid trisodium accumulates in methylmalonic and propionic acidemias and acts as a marker metabolite. 2-Methylcitric acid trisodium markedly inhibits ADP-stimulated and uncoupled respiration in mitochondria supported by glutamate[1].